{"product_id":"ventricular-assist-device-kpi-metrics","title":"What 5 KPIs Should Ventricular Assist Device Services Track?","description":"\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"line_top\"\u003e\u003c\/div\u003e\n\u003ch2\u003eKPI Metrics for Ventricular Assist Device Services\u003c\/h2\u003e\n\u003cp\u003eTracking key performance indicators (KPIs) is non-negotiable for Ventricular Assist Device Services, given the high fixed costs and regulatory burden Focus on 7 core metrics across utilization, patient outcomes, and profitability In 2026, your total variable costs (COGS and operating) start near 195% of revenue, leaving a strong gross margin, but fixed costs are $39,500 monthly You hit breakeven fast-in just 2 months (February 2026)-but must manage capacity utilization, which starts low (eg, Cardiothoracic Surgeons at 450% capacity) Review financial metrics monthly and clinical outcomes quarterly for maximum control\n\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\" id=\"main_article_image\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #6067F2;\"\u003e7 KPIs to Track for \u003c\/span\u003eVentricular Assist Device Services\u003c\/h2\u003e\u003cbr\u003e\n\u003ctable id=\"dwnld_tbl_id\"\u003e\n\u003ctr\u003e\n\u003cth\u003e#\u003c\/th\u003e\n\u003cth\u003eKPI Name\u003c\/th\u003e\n\u003cth\u003eMetric Type\u003c\/th\u003e\n\u003cth\u003eTarget \/ Benchmark\u003c\/th\u003e\n\u003cth\u003eReview Frequency\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e1\u003c\/td\u003e\n\u003ctd\u003eMonthly Treatment Volume\u003c\/td\u003e\n\u003ctd\u003eVolume\u003c\/td\u003e\n\u003ctd\u003eConsistent month-over-month growth (sum of all roles' treatments, e.g., 8 Surgeon + 40 Coordinator treatments in 2026)\u003c\/td\u003e\n\u003ctd\u003eWeekly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2\u003c\/td\u003e\n\u003ctd\u003eGross Margin Percentage (GM%)\u003c\/td\u003e\n\u003ctd\u003eProfitability\u003c\/td\u003e\n\u003ctd\u003eAbove 800% (starts at 805% in 2026); calculated as (Revenue - COGS) \/ Revenue\u003c\/td\u003e\n\u003ctd\u003eMonthly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e3\u003c\/td\u003e\n\u003ctd\u003eClinical Capacity Utilization\u003c\/td\u003e\n\u003ctd\u003eEfficiency\u003c\/td\u003e\n\u003ctd\u003eExceed 600% quickly; Actual Billed Procedures \/ Maximum Capacity Procedures (e.g., 450% for Surgeons in 2026)\u003c\/td\u003e\n\u003ctd\u003eWeekly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e4\u003c\/td\u003e\n\u003ctd\u003eVariable Cost per Procedure\u003c\/td\u003e\n\u003ctd\u003eCost Control\u003c\/td\u003e\n\u003ctd\u003eAnnual reduction; Kits must drop from 80% to 60% of cost by 2030\u003c\/td\u003e\n\u003ctd\u003eMonthly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e5\u003c\/td\u003e\n\u003ctd\u003eAverage Revenue per FTE\u003c\/td\u003e\n\u003ctd\u003eProductivity\u003c\/td\u003e\n\u003ctd\u003eConsistent increase reflecting volume growth and pricing adjustments\u003c\/td\u003e\n\u003ctd\u003eMonthly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e6\u003c\/td\u003e\n\u003ctd\u003eCash Runway in Months\u003c\/td\u003e\n\u003ctd\u003eLiquidity\u003c\/td\u003e\n\u003ctd\u003e12+ months, especially before the Jun-26 minimum cash requirement of $483k\u003c\/td\u003e\n\u003ctd\u003eWeekly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7\u003c\/td\u003e\n\u003ctd\u003eFixed Overhead Coverage Ratio\u003c\/td\u003e\n\u003ctd\u003eStability\u003c\/td\u003e\n\u003ctd\u003eConsistently above 10x Gross Profit \/ Total Monthly Fixed Expenses ($39,500)\u003c\/td\u003e\n\u003ctd\u003eMonthly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cdiv class=\"dwnld_btn_div\"\u003e\u003cbutton id=\"dwnld_btn_id\" class=\"dwnld_btn_clss\"\u003eDownload Table in XLSX\u003c\/button\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eHow quickly can we achieve positive cash flow and return capital to investors?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eThe Ventricular Assist Device Services model projects reaching breakeven by \u003cstrong\u003eFebruary 2026\u003c\/strong\u003e, requiring \u003cstrong\u003e17 months\u003c\/strong\u003e to pay back initial capital, which supports an aggressive target Internal Rate of Return of \u003cstrong\u003e1365%\u003c\/strong\u003e; you'll defintely want to review \u003ca href=\"\/blogs\/profitability\/ventricular-assist-device\"\u003eHow Increase Ventricular Assist Device Services Profitability?\u003c\/a\u003e for deeper operational levers.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eCash Flow Milestones\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eBreakeven date is set for \u003cstrong\u003eFeb-26\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003ePayback period clocks in at \u003cstrong\u003e17 months\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eThis timeline requires careful management of initial burn.\u003c\/li\u003e\n\u003cli\u003eWe must hit utilization targets early on.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eCapital Requirements\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTarget Internal Rate of Return (IRR) is \u003cstrong\u003e1365%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eMinimum cash requirement hits \u003cstrong\u003e$483k\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eThat $483k must be secured by \u003cstrong\u003eJune 2026\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eThis runway supports the aggressive growth needed for that IRR.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eAre we maximizing the utilization of high-cost clinical staff, like surgeons and perfusionists?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eYour Ventricular Assist Device Services model projects extreme staff scaling by 2026, where surgeon capacity hits \u003cstrong\u003e450%\u003c\/strong\u003e and coordinator capacity hits \u003cstrong\u003e500%\u003c\/strong\u003e, meaning utilization hinges entirely on securing enough case volume to justify this hiring plan. Before you hire against these projections, review how much an owner makes from these services to ensure the unit economics support the overhead growth, as detailed in \u003ca href=\"\/blogs\/how-much-makes\/ventricular-assist-device\"\u003eHow Much Does An Owner Make From Ventricular Assist Device Services?\u003c\/a\u003e. Honestly, you've built in massive headroom, but that headroom costs money if unused. Defintely watch your fixed costs climb before the revenue does.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eStaff Capacity Targets by 2026\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eSurgeon capacity scales to \u003cstrong\u003e450%\u003c\/strong\u003e of current levels.\u003c\/li\u003e\n\u003cli\u003eCoordinator capacity reaches \u003cstrong\u003e500%\u003c\/strong\u003e utilization potential.\u003c\/li\u003e\n\u003cli\u003ePerfusionist capacity is planned for \u003cstrong\u003e400%\u003c\/strong\u003e growth.\u003c\/li\u003e\n\u003cli\u003eThese figures show massive planned throughput increase.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eStaffing Ratio Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eMaintain the planned \u003cstrong\u003e1 Surgeon to 2 Perfusionists\u003c\/strong\u003e ratio.\u003c\/li\u003e\n\u003cli\u003eThis ratio dictates required perfusionist hiring volume.\u003c\/li\u003e\n\u003cli\u003eIf case volume lags, perfusionists become your highest idle cost.\u003c\/li\u003e\n\u003cli\u003eFocus sales efforts on driving implantation procedures first.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eWhere are the most significant variable cost levers we can pull to improve gross margin?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eYour gross margin is currently negative because variable costs are projected at \u003cstrong\u003e195%\u003c\/strong\u003e of revenue in 2026, meaning you must immediately cut costs just to cover the cost of goods sold. The single biggest lever you can pull is negotiating the price of VAD Surgical Kits and Consumables, which account for \u003cstrong\u003e80%\u003c\/strong\u003e of projected revenue. If you're looking at the overall economics of this service, check out the analysis on \u003ca href=\"\/blogs\/how-much-makes\/ventricular-assist-device\"\u003eHow Much Does An Owner Make From Ventricular Assist Device Services?\u003c\/a\u003e\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eTarget VAD Kit Costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eVAD Surgical Kits and Consumables represent \u003cstrong\u003e80%\u003c\/strong\u003e of 2026 revenue.\u003c\/li\u003e\n\u003cli\u003eThis line item is your primary focus for margin improvement.\u003c\/li\u003e\n\u003cli\u003eDemand volume discounts from suppliers immediately.\u003c\/li\u003e\n\u003cli\u003eEven a small percentage drop here yields massive dollar impact.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eLogistics and Scale Benefits\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eSterile Logistics and Handling costs are \u003cstrong\u003e25%\u003c\/strong\u003e of revenue.\u003c\/li\u003e\n\u003cli\u003eOptimize routing and handling protocols to reduce this spend.\u003c\/li\u003e\n\u003cli\u003eScaling operations reduces Medical Malpractice Insurance premiums by \u003cstrong\u003e60%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eThis insurance benefit is a long-term lever, not an immediate fix.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eHow fast must we scale treatment volume to justify increased fixed overhead and clinical hiring?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eTo justify the necessary fixed overhead, especially hiring specialized clinical staff, Ventricular Assist Device Services must achieve a revenue growth rate from \u003cstrong\u003e$17 million in Year 1\u003c\/strong\u003e to \u003cstrong\u003e$272 million by Year 5\u003c\/strong\u003e. This aggressive trajectory is essential to convert modest initial EBITDA of \u003cstrong\u003e$319 thousand\u003c\/strong\u003e into substantial profitability of \u003cstrong\u003e$235 million\u003c\/strong\u003e by Year 5; understanding this scaling path is key to managing early operational burn, and you can read more about \u003ca href=\"\/blogs\/profitability\/ventricular-assist-device\"\u003eHow Increase Ventricular Assist Device Services Profitability?\u003c\/a\u003e\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eJustifying Clinical Hires\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eNeed \u003cstrong\u003e20 Telehealth Nurses\u003c\/strong\u003e hired by 2030 to manage volume.\u003c\/li\u003e\n\u003cli\u003eSurgeon treatment capacity must rise from 4 to 6 monthly procedures by 2030.\u003c\/li\u003e\n\u003cli\u003eFixed overhead increases sharply with specialized clinical onboarding.\u003c\/li\u003e\n\u003cli\u003eVolume growth must outpace hiring lag to maintain margin, defintely.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eThe EBITDA Leverage Path\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eYear 1 EBITDA sits at \u003cstrong\u003e$319k\u003c\/strong\u003e against $17M revenue.\u003c\/li\u003e\n\u003cli\u003eYear 5 projects EBITDA reaching \u003cstrong\u003e$235M\u003c\/strong\u003e on $272M revenue.\u003c\/li\u003e\n\u003cli\u003eThis shows massive operating leverage kicking in after initial fixed costs.\u003c\/li\u003e\n\u003cli\u003eIf onboarding takes 14+ days, churn risk rises for monthly recurring fees.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\n\n\u003cdiv class=\"double_border\"\u003e\n\n\u003cdiv class=\"card_smpl_header\"\u003e\n\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\n\u003ch3\u003eKey Takeaways\u003c\/h3\u003e\n\n\u003c\/div\u003e\n\n\u003cul class=\"lst_crct_blog\"\u003e\n\n\u003cli\u003eVentricular Assist Device Services exhibit strong initial financial potential, reaching breakeven in just two months and targeting a high Internal Rate of Return (IRR) of 1365%.\u003c\/li\u003e\n\n\u003cli\u003eManaging the high initial variable cost structure, where VAD Surgical Kits account for 80% of revenue, is critical for improving gross margin and long-term profitability.\u003c\/li\u003e\n\n\u003cli\u003eCapacity utilization for high-cost clinical staff, such as surgeons and coordinators, must be aggressively managed weekly to ensure sufficient throughput covers the $39,500 monthly fixed overhead.\u003c\/li\u003e\n\n\u003cli\u003eOperational success hinges on balancing rapid volume scaling with tight cost control, requiring monthly financial reviews and weekly checks on clinical capacity metrics.\u003c\/li\u003e\n\n\u003c\/ul\u003e\n\n\u003c\/div\u003e\n\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 1\n: \u003cspan style=\"color: #126CFF;\"\u003eMonthly Treatment Volume\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eMonthly Treatment Volume is simply the total count of procedures or patient visits logged by everyone on your team each month. This metric sums up every interaction, like \u003cstrong\u003eSurgeon\u003c\/strong\u003e implantations plus \u003cstrong\u003eCoordinator\u003c\/strong\u003e patient check-ins. It's your primary measure of operational activity and capacity usage.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eShows the raw scaling speed of your outsourced program.\u003c\/li\u003e\n\u003cli\u003eDirectly correlates to fee-for-service revenue potential.\u003c\/li\u003e\n\u003cli\u003eHelps forecast staffing needs across clinical roles.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eVolume alone doesn't show revenue quality or margin.\u003c\/li\u003e\n\u003cli\u003eIt can hide inefficiencies if low-value tasks inflate the count.\u003c\/li\u003e\n\u003cli\u003eIt's less useful than utilization if capacity isn't fully defined.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFor specialized, high-acuity services like VAD management, benchmarks focus less on absolute numbers and more on consistency. The goal isn't just hitting a number, but achieving \u003cstrong\u003econsistent month-over-month growth\u003c\/strong\u003e. If you are already running at \u003cstrong\u003e450% utilization\u003c\/strong\u003e for Surgeons, any volume increase must come from new hospital contracts, not just squeezing current staff harder.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eAggressively close new hospital partnerships for implantation slots.\u003c\/li\u003e\n\u003cli\u003eOptimize scheduling to reduce surgeon idle time between procedures.\u003c\/li\u003e\n\u003cli\u003eStandardize coordinator workflows to handle higher patient loads efficiently.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou calculate this by summing every procedure or visit logged by every role during the month. This is a simple addition exercise across your operational ledger.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nTotal Monthly Treatments = $\\sum (\\text{Surgeon Treatments} + \\text{Coordinator Treatments} + \\text{Other Role Treatments})$\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cbr\u003e\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSay you are looking at the 2026 projection where your fixed overhead is \u003cstrong\u003e$39,500\u003c\/strong\u003e per month. If your team completed \u003cstrong\u003e8 Surgeon\u003c\/strong\u003e procedures and \u003cstrong\u003e40 Coordinator\u003c\/strong\u003e follow-up visits that month, your total volume is 48 treatments.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nTotal Monthly Treatments = 8 + 40 = 48\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTrack volume growth weekly, not just monthly.\u003c\/li\u003e\n\u003cli\u003eSegment volume by procedure type (Implant vs. Management).\u003c\/li\u003e\n\u003cli\u003eIf volume is flat, check the sales pipeline conversion rate.\u003c\/li\u003e\n\u003cli\u003eIf volume rises but utilization doesn't, you defintely need more FTEs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e \u003ch2\u003eKPI 2\n: \u003cspan style=\"color: #126CFF;\"\u003eGross Margin Percentage (GM%)\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eGross Margin Percentage (GM%) shows your profitability after subtracting the direct costs of delivering your outsourced Ventricular Assist Device (VAD) service. It measures how much revenue remains to cover overhead and profit. This metric is key because it confirms if your fee-for-service pricing structure is sound before considering fixed expenses like your \u003cstrong\u003e$39,500\u003c\/strong\u003e monthly overhead.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eShows core profitability per procedure.\u003c\/li\u003e\n\u003cli\u003eGuides negotiations on VAD Kit costs.\u003c\/li\u003e\n\u003cli\u003eHighlights efficiency in direct service delivery.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIgnores the burden of fixed overhead costs.\u003c\/li\u003e\n\u003cli\u003eThe \u003cstrong\u003e800%+\u003c\/strong\u003e target is highly unusual for a percentage.\u003c\/li\u003e\n\u003cli\u003eDoesn't reflect overall operational health alone.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFor outsourced medical services, a standard Gross Margin Percentage often falls between 40% and 60%. Your internal target of starting at \u003cstrong\u003e805%\u003c\/strong\u003e in 2026 is far outside typical ranges. This suggests the metric might be tracking Gross Profit as a multiple of COGS, or it represents an extremely high-margin, specialized service where variable costs are near zero. You must defintely confirm this internal definition.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eAggressively reduce Variable Cost per Procedure.\u003c\/li\u003e\n\u003cli\u003eIncrease the recurring monthly management fee component.\u003c\/li\u003e\n\u003cli\u003eMaximize Clinical Capacity Utilization to spread fixed costs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou calculate Gross Margin Percentage by taking total revenue, subtracting the Cost of Goods Sold (COGS), and dividing that result by the total revenue. COGS here includes direct costs like VAD kits and associated logistics for each procedure.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nGM% = (Revenue - COGS) \/ Revenue\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eIf your total revenue for a month is $500,000 and your direct costs (COGS) for those procedures totaled $50,000, you would calculate the margin like this:\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nGM% = ($500,000 - $50,000) \/ $500,000 = 0.90 or 90%\n\u003c\/div\u003e\n\u003cp\u003eThis example shows a 90% margin, which is far below your required target of \u003cstrong\u003e805%\u003c\/strong\u003e, highlighting the need to understand the specific components driving your internal metric.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eReview this figure exactly \u003cstrong\u003emonthly\u003c\/strong\u003e as required.\u003c\/li\u003e\n\u003cli\u003eEnsure COGS includes all direct practitioner time costs.\u003c\/li\u003e\n\u003cli\u003eIf utilization is low, GM% improvement is harder to achieve.\u003c\/li\u003e\n\u003cli\u003eTrack the trend toward the \u003cstrong\u003e805%\u003c\/strong\u003e starting point in 2026.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 3\n: \u003cspan style=\"color: #126CFF;\"\u003eClinical Capacity Utilization\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eClinical Capacity Utilization measures how much of your available staff time is actually generating revenue through billed procedures or management services. This KPI is vital because your business model relies on deploying highly specialized personnel efficiently across partner hospitals. For CardiaVance Solutions, low utilization means expensive expertise sits idle, directly hurting your fee-for-service income.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eShows exactly where scheduling bottlenecks prevent revenue capture.\u003c\/li\u003e\n\u003cli\u003eHelps justify staffing decisions by linking personnel costs to billable output.\u003c\/li\u003e\n\u003cli\u003eDrives operational focus toward increasing procedure density per provider shift.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eHigh utilization can mask poor quality if staff rush complex VAD management tasks.\u003c\/li\u003e\n\u003cli\u003eIt doesn't account for non-billable but necessary activities like training or compliance.\u003c\/li\u003e\n\u003cli\u003eIf capacity definitions aren't updated as protocols change, the metric becomes useless.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFor outsourced clinical services, benchmarks are aggressive because you are selling specialized, high-margin expertise. While general hospital utilization might be 80%, your target for specialized roles like Surgeons must quickly exceed \u003cstrong\u003e600%\u003c\/strong\u003e. This high number reflects the ability to stack billable ongoing patient management tasks around core surgical procedures. You need to be above \u003cstrong\u003e600%\u003c\/strong\u003e to support the high Gross Margin Percentage target of 805%.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eReview utilization data every week to catch underperformance fast.\u003c\/li\u003e\n\u003cli\u003eStandardize the scheduling template for ongoing patient management slots.\u003c\/li\u003e\n\u003cli\u003eImprove referral flow speed to reduce surgeon downtime between cases.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou calculate this by dividing the total number of procedures or billable management interactions your staff actually completed by the maximum number of billable interactions they theoretically could have completed in that period. This measures output against potential output.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nClinical Capacity Utilization = Actual Billed Procedures \/ Maximum Capacity Procedures\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eIf your surgeons have a theoretical maximum capacity to handle 100 billable VAD management events and 10 surgical procedures in a month (total capacity units defined as 100), but they only complete 450 billable events, the utilization is calculated as follows. Remember, this metric is about maximizing the use of specialized time, so the resulting percentage is often high.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nSurgeon Utilization (2026) = 450 Actual Billed Procedures \/ 100 Maximum Capacity Procedures = 450%\n\u003c\/div\u003e\n\u003cp\u003eThis means the surgeons are operating at 4.5 times their baseline scheduled capacity, likely due to efficient stacking of ongoing management fees around surgical windows.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eDefine Maximum Capacity Procedures based on realistic scheduling constraints.\u003c\/li\u003e\n\u003cli\u003eSegment utilization by role; Surgeons and Coordinators will have different targets.\u003c\/li\u003e\n\u003cli\u003eIf utilization drops below \u003cstrong\u003e580%\u003c\/strong\u003e, investigate scheduling software integration issues.\u003c\/li\u003e\n\u003cli\u003eTrack utilization variance weekly; a \u003cstrong\u003e5%\u003c\/strong\u003e swing signals a defintely operational shift.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 4\n: \u003cspan style=\"color: #126CFF;\"\u003eVariable Cost per Procedure\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou need to know what it costs, dollar for dollar, to complete one procedure. This metric, \u003cstrong\u003eVariable Cost per Procedure (VCP)\u003c\/strong\u003e, sums up everything that changes when you do one more case-consumables, shipping, and insurance. It's the baseline cost we must beat every month to make money.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eDirectly impacts contribution margin on every case.\u003c\/li\u003e\n\u003cli\u003eHighlights major cost drivers, like \u003cstrong\u003eVAD Kits\u003c\/strong\u003e spend.\u003c\/li\u003e\n\u003cli\u003eSupports better long-term supplier negotiations.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIgnores fixed overhead costs entirely.\u003c\/li\u003e\n\u003cli\u003eCan look artificially low if procedure volume is inconsistent.\u003c\/li\u003e\n\u003cli\u003eDoesn't measure the quality of the supplies used.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFor outsourced medical services like this, VCP benchmarks vary wildly based on the complexity of the device and the scope of management included in the fee. What matters more than an external number is hitting your internal goal: reducing the \u003cstrong\u003eVAD Kit\u003c\/strong\u003e portion of this cost from \u003cstrong\u003e80%\u003c\/strong\u003e down to \u003cstrong\u003e60%\u003c\/strong\u003e by \u003cstrong\u003e2030\u003c\/strong\u003e. This target shows operational maturity.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eAggressively renegotiate \u003cstrong\u003eVAD Kit\u003c\/strong\u003e pricing based on volume forecasts.\u003c\/li\u003e\n\u003cli\u003eStandardize logistics processes to cut shipping waste and cost.\u003c\/li\u003e\n\u003cli\u003eAudit data usage monthly to ensure software licenses scale efficiently.\u003c\/li\u003e\n\u003cli\u003eIf onboarding takes 14+ days, churn risk rises, increasing replacement costs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou calculate VCP by summing all direct, per-procedure expenses and dividing that total by the number of procedures performed in the period. This must be reviewed monthly to catch cost creep fast.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nVCP = (VAD Kits + Logistics + Insurance + Data) \/ Total Procedures\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSay in one month, your total spend on kits, shipping, insurance, and data tracking added up to $150,000. If your team completed \u003cstrong\u003e100\u003c\/strong\u003e VAD procedures that same month, here's the quick math on your cost per case.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nVCP = ($150,000) \/ 100 Procedures = $1,500 per Procedure\n\u003c\/div\u003e\n\u003cp\u003eIf your average revenue per procedure is $10,000, that $1,500 VCP is manageable, but we defintely need to drive that down.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eReview VCP components against the \u003cstrong\u003e80% Kit\u003c\/strong\u003e baseline every 30 days.\u003c\/li\u003e\n\u003cli\u003eTrack Logistics cost per mile, not just total spend, for better control.\u003c\/li\u003e\n\u003cli\u003eSet interim cost-down targets for Kits leading up to the \u003cstrong\u003e2030\u003c\/strong\u003e goal.\u003c\/li\u003e\n\u003cli\u003eEnsure Data costs are tied to actual patient load, not just fixed software seats.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 5\n: \u003cspan style=\"color: #126CFF;\"\u003eAverage Revenue per FTE\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eAverage Revenue per FTE (ARPFTE) tells you how much revenue each full-time clinical employee generates monthly. This metric is crucial for understanding staffing efficiency, especially when your service relies on specialized clinical staff like surgeons and coordinators. A rising ARPFTE means you are getting more revenue from the same team size, or you are scaling revenue faster than headcount.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eGuides hiring decisions based on revenue capacity.\u003c\/li\u003e\n\u003cli\u003eValidates if price adjustments translate to better output.\u003c\/li\u003e\n\u003cli\u003eTracks efficiency gains from better scheduling or volume.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIgnores how busy each FTE actually is (utilization).\u003c\/li\u003e\n\u003cli\u003eDoesn't account for high fixed overhead costs.\u003c\/li\u003e\n\u003cli\u003eCan mask low-value work if overall treatment volume is high.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eBenchmarks vary widely based on service complexity and pricing structure. For high-touch, specialized outsourced medical services like VAD management, you should aim for an ARPFTE significantly higher than general administrative roles. If your implantation fee is substantial, your target ARPFTE will naturally be higher than centers focused only on routine follow-ups. You need to compare your ARPFTE against similar outsourced clinical service providers, not general hospital staff.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIncrease Monthly Treatment Volume without adding clinical FTEs.\u003c\/li\u003e\n\u003cli\u003eReview and adjust recurring monthly management fees annually.\u003c\/li\u003e\n\u003cli\u003eImprove Clinical Capacity Utilization (target should exceed \u003cstrong\u003e600%\u003c\/strong\u003e quickly).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eTo find your revenue efficiency, divide your total monthly revenue by the number of clinical full-time employees you have on staff. This calculation focuses strictly on the revenue-generating clinical team, excluding administrative or sales staff.\u003c\/p\u003e\n\u003cbr\u003e\n\u003cbr\u003e\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSay your total revenue from implantation fees and monthly management fees hits \u003cstrong\u003e$500,000\u003c\/strong\u003e for the month of May. If you currently have \u003cstrong\u003e10\u003c\/strong\u003e dedicated clinical FTEs managing those c\nases, here's the quick math on efficiency.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003eTotal Monthly Revenue \/ Total Clinical FTEs = ARPFTE\u003c\/div\u003e\n\u003cp\u003eUsing the numbers: \u003cstrong\u003e$500,000 \/ 10 FTEs = $50,000\u003c\/strong\u003e per FTE. If next month revenue hits $520,000 but FTEs stay at 10, your ARPFTE improves to $52,000, showing better efficiency.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eSegment ARPFTE by role (Surgeon vs. Coordinator FTEs).\u003c\/li\u003e\n\u003cli\u003eTrack ARPFTE against the Fixed Overhead Coverage Ratio of \u003cstrong\u003e10x\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eEnsure FTE counts only include staff directly tied to treatment delivery.\u003c\/li\u003e\n\u003cli\u003eIf ARPFTE stalls, review pricing adjustments before hiring new staff; it's defintely a warning sign.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 6\n: \u003cspan style=\"color: #126CFF;\"\u003eCash Runway in Months\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eCash Runway in Months tells you exactly how long your company can keep the lights on using the cash you have right now. It's the ultimate survival metric for any startup, especially one scaling specialized services like outsourced VAD programs. If you aren't profitable yet, this number dictates your fundraising timeline and operational pacing.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eGives you time to secure the next funding round without pressure.\u003c\/li\u003e\n\u003cli\u003eLets you negotiate better terms with hospital partners.\u003c\/li\u003e\n\u003cli\u003ePrevents rash decisions when facing unexpected operational delays.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIt assumes your Net Burn Rate stays constant, which rarely happens.\u003c\/li\u003e\n\u003cli\u003eIt hides underlying operational inefficiencies if cash is high.\u003c\/li\u003e\n\u003cli\u003eA long runway can mask slow progress toward positive cash flow.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFor service businesses relying on large contracts, like providing VAD support to regional medical centers, \u003cstrong\u003e12 months\u003c\/strong\u003e is the baseline minimum target. You need this buffer because securing a new hospital partner can take 6 to 9 months of diligence. If your runway drops below \u003cstrong\u003e6 months\u003c\/strong\u003e, you are in reactive mode, which hurts long-term partnership negotiations.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eAggressively push Clinical Capacity Utilization above \u003cstrong\u003e600%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eEnsure monthly management fee collections are timely; reduce Days Sales Outstanding.\u003c\/li\u003e\n\u003cli\u003eKeep fixed overhead, currently \u003cstrong\u003e$39,500\u003c\/strong\u003e monthly, covered at least \u003cstrong\u003e10x\u003c\/strong\u003e by Gross Profit.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eTo find your runway, you divide your current cash reserves by how much cash you lose each month. Net Burn Rate is the total operating expenses minus revenue, or simply your negative Net Income. You must monitor this weekly because cash is finite.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nCash Runway (Months) = Current Cash Balance \/ Net Burn Rate\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eIf you project needing a minimum of \u003cstrong\u003e$483k\u003c\/strong\u003e cash on hand by \u003cstrong\u003eJun-26\u003c\/strong\u003e, and your current projected monthly loss (Net Burn Rate) is \u003cstrong\u003e$45,000\u003c\/strong\u003e, you have a runway of about 10.7 months. This means you must secure new funding or become profitable before that 11th month hits. Here's the quick math:\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nCash Runway = $483,000 \/ $45,000 = 10.7 Months\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eReview this metric every single week, not monthly.\u003c\/li\u003e\n\u003cli\u003eModel scenarios where a major hospital delays payment by 60 days.\u003c\/li\u003e\n\u003cli\u003eIf runway dips below \u003cstrong\u003e15 months\u003c\/strong\u003e, start investor conversations immediately.\u003c\/li\u003e\n\u003cli\u003eEnsure your projected cash balance never touches the \u003cstrong\u003e$483k\u003c\/strong\u003e floor before \u003cstrong\u003eJun-26\u003c\/strong\u003e; defintely aim higher.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 7\n: \u003cspan style=\"color: #126CFF;\"\u003eFixed Overhead Coverage Ratio\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThe Fixed Overhead Coverage Ratio shows how many times your gross profit can pay your fixed monthly bills. It's the key metric for measuring your operational safety margin above break-even. For your outsourced VAD program, you must cover \u003cstrong\u003e$39,500\u003c\/strong\u003e in total monthly fixed expenses to stay afloat.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eShows your safety cushion above the break-even point.\u003c\/li\u003e\n\u003cli\u003eForces focus on gross margin quality, not just raw sales volume.\u003c\/li\u003e\n\u003cli\u003eIndicates financial stability for lenders or future funding rounds.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIt hides the actual cash position if accounts receivable are slow to collect.\u003c\/li\u003e\n\u003cli\u003eA very high ratio can mask inefficiency if variable costs are creeping up unnoticed.\u003c\/li\u003e\n\u003cli\u003eIt doesn't factor in one-time capital expenditures needed for expansion.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFor specialized, high-margin service businesses like outsourced clinical programs, stability is paramount. While general benchmarks often look for 3x to 5x coverage, your target of \u003cstrong\u003e10x\u003c\/strong\u003e is aggressive and appropriate given the high fixed cost base of specialized personnel. Consistently hitting 10x means you have significant breathing room before operational changes impact viability.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eDrive up the recurring monthly management fee component of your revenue stream.\u003c\/li\u003e\n\u003cli\u003eAggressively reduce the cost of VAD Kits, aiming for the \u003cstrong\u003e60%\u003c\/strong\u003e target by 2030.\u003c\/li\u003e\n\u003cli\u003eEnsure clinical capacity utilization exceeds \u003cstrong\u003e600%\u003c\/strong\u003e to maximize revenue from existing fixed staff salaries.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou calculate this by taking your total Gross Profit for the month and dividing it by your Total Monthly Fixed Expenses. This shows you the margin buffer you have before those fixed costs start burning cash. Remember, Gross Profit is Revenue minus Cost of Goods Sold (COGS), which in your case includes direct costs like supplies and insurance tied to each procedure.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nFixed Overhead Coverage Ratio = Gross Profit \/ Total Monthly Fixed Expenses\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cbr\u003e\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSay your VAD implantation fees and management revenue generated \u003cstrong\u003e$550,000\u003c\/strong\u003e in Gross Profit last month, after accounting for direct costs like VAD Kits and insurance. Your fixed overhead, including core salaries and office space, remains steady at \u003cstrong\u003e$39,500\u003c\/strong\u003e. You divide the profit by the fixed cost to see your coverage.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\n$550,000 \/ $39,500 = 13.92x\n\u003c\/div\u003e\n\u003cp\u003eThis result of \u003cstrong\u003e13.92x\u003c\/strong\u003e means your gross profit covered all fixed costs nearly fourteen times over, giving you a very strong operational cushion.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eReview this metric weekly, not just monthly, given the high fixed base.\u003c\/li\u003e\n\u003cli\u003eDirectly link Gross Profit growth to Clinical Capacity Utilization rates.\u003c\/li\u003e\n\u003cli\u003eModel the impact of a single month below \u003cstrong\u003e8x\u003c\/strong\u003e coverage immediately.\u003c\/li\u003e\n\u003cli\u003eConfirm that the \u003cstrong\u003e$39,500\u003c\/strong\u003e figure excludes all variable costs like consumables. I think this is a defintely important check.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e","brand":"FinancialModelsLab","offers":[{"title":"Default Title","offer_id":49304351867123,"sku":"ventricular-assist-device-kpi-metrics","price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0522\/6191\/2762\/files\/ventricular-assist-device-kpi-metrics.webp?v=1782694697","url":"https:\/\/financialmodelslab.com\/products\/ventricular-assist-device-kpi-metrics","provider":"Financial Models Lab","version":"1.0","type":"link"}